B-CELL LYMPHOID MALIGNANCIES

Clinical trials for B-CELL LYMPHOID MALIGNANCIES explained in plain language.

Never miss a new study

Get alerted when new B-CELL LYMPHOID MALIGNANCIES trials appear

Sign up with your email to follow new studies for B-CELL LYMPHOID MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Completed 1

First test of new cancer drug in humans begins

Disease control Terminated

This was an early-stage trial to test the safety and find the right dose of a new drug called ESG206 for adults with advanced B-cell blood cancers like lymphoma. The study was for people whose cancer had worsened despite standard treatments and who had no other good options. Rese…

Matched conditions: B-CELL LYMPHOID MALIGNANCIES

Phase: PHASE1 • Sponsor: Shanghai Escugen Biotechnology Co., Ltd • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

B-CELL LYMPHOID MALIGNANCIES

Get alerted when new B-CELL LYMPHOID MALIGNANCIES trials appear

First test of new cancer drug in humans begins